Drug-lipid interaction evaluation: Why a 19th century solution?

Trends in Pharmacological Sciences

Volumn 31, Issue 10, 2010, Pages 449-454

  Ribeiro, Marta M B ^a   Melo, Manuel N ^a   Serrano, Isa D ^a   Santos, Nuno C ^a   Castanho, Miguel A R B ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

OCTANOL; WATER;

ARTICLE; DRUG BINDING; DRUG DEVELOPMENT; DRUG SCREENING; HIGH THROUGHPUT SCREENING; LIPID BILAYER; LIPID COMPOSITION; LIPID MEMBRANE; LIPID VESICLE; LIPOPHILICITY; MEMBRANE BINDING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; THERMODYNAMICS;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HISTORY, 19TH CENTURY; HUMANS; MEMBRANES; PHARMACEUTICAL PREPARATIONS;

EID: 77956909526     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2010.06.007     Document Type: Article

References (58)

1. Castanho M.A., Fernandes M.X. Lipid membrane-induced optimization for ligand-receptor docking: recent tools and insights for the " membrane catalysis" model. Eur. Biophys. J. 2006, 35:92-103.
2. Melo M.N., et al. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 2009, 7:245-250.
3. Ben-Dror S., et al. On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers. Photochem. Photobiol. 2006, 82:695-701.
4. Domingues M.M., et al. Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)). Biophys. J. 2009, 96:987-996.
5. Sargent D.F., Schwyzer R. Membrane lipid phase as catalyst for peptide-receptor interactions. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:5774-5778.
6. Singer S.J., Nicolson G.L. Fluid mosaic model of structure of cell-membranes. Science 1972, 175:720-731.
7. Mouritsen O.G., Andersen O.S. Do we need a new biomembrane model?. Biol. Skr. Dan. Vid. Selsk. 1998, 49:7-12.
8. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
9. Dennis E.A. Lipidomics joins the omics evolution. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2089-2090.
10. Riezman H., van Meer G. Lipid pickup and delivery. Nat. Cell Biol. 2004, 6:15-16.
11. Semrau S., Schmidt T. Membrane heterogeneity - from lipid domains to curvature effects. Soft Matter 2009, 5:3174-3186.
12. Sanchez S.A., Gratton E. Lipid-protein interactions revealed by two-photon microscopy and fluorescence correlation spectroscopy. Acc. Chem. Res. 2005, 38:469-477.
13. Muller D.J. AFM: a nanotool in membrane biology. Biochemistry 2008, 47:7986-7998.
14. Santos N.C., Castanho M.A.R.B. An overview of the biophysical applications of atomic force microscopy. Biophys. Chem. 2004, 107:133-149.
15. Berthelot M., Jungfleisch E. Sur les lois qui president ou partage d'un corps entre deux dissolvants (experiences). Ann. Chim. Phys. 1872, 26:396-407.
16. Nernst, W. (1891) Verteilung eines Stoffes zwischen zwei Lösungsmitteln und zwischen Lösungsmittel und Dampfraum. Z. Phys. Chem. 1891, 110-139.
17. Meyer H. Zur Theorie der Alkoholnarkose. Arch. Exptl. Pathol. Pharmakol. 1899, 42:109-118.
18. Overton E. Studien uber die Narkose 1901, Verlag von Gustav Fischer.
19. Ghose A.K., et al. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods. J. Phys. Chem. A 1998, 102:3762-3772.
20. Caron G., et al. Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects. Pharm. Sci. Technol. Today 1999, 2:327-335.
21. Clark D.E., Pickett S.D. Computational methods for the prediction of 'drug-likeness'. Drug Discov. Today 2000, 5:49-58.
22. Tetko I.V., et al. Can we estimate the accuracy of ADME-Tox predictions?. Drug Discov. Today 2006, 11:700-707.
23. Austin R.P., et al. Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. J. Pharm. Sci. 1995, 84:1180-1183.
24. Wallace B.A., et al. Conformation of gramicidin A in phospholipid vesicles: circular dichroism studies of effects of ion binding, chemical modification, and lipid structure. Biochemistry 1981, 20:5754-5760.
25. Wells J.I. Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances 1988, Ellis Horwood Ltd.
26. Santos N.C., et al. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim. Biophys. Acta 2003, 1612:123-135.
27. Guggenheim E.A. Mixtures 1952, Oxford University Press.
28. Staverman A.J., Van Santen J.H. The entropy of liquid mixtures. Rec. Trav. Chim. Pay. B 1941, 60:76-84.
29. Lopes S.C.D.N., et al. Lipidic membranes are potential " catalysts" in the ligand activity of the multifunctional pentapeptide neokyotorphin. Chem. Bio. Chem. 2005, 6:697-702.
30. Marsh D. Cholesterol-induced fluid membrane domains: a compendium of lipid-raft ternary phase diagrams. Biochim. Biophys. Acta 2009, 1788:2114-2123.
31. Matos P.M., et al. Interaction of peptides with biomembranes assessed by potential-sensitive fluorescent probes. J. Pept. Sci. 2008, 14:407-415.
32. Kramer S.D., Wunderli-Allenspach H. The pH-dependence in the partitioning behaviour of (RS)-[3H]propranolol between MDCK cell lipid vesicles and buffer. Pharm. Res. 1996, 13:1851-1855.
33. Taillardat-Bertschinger A., et al. Immobilized artificial membrane HPLC in drug research. J. Med. Chem. 2003, 46:655-665.
34. Ong S., et al. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces. Anal. Chem. 1995, 67:755-762.
35. Kaminoh Y., et al. Membrane-buffer partition coefficients of tetracaine for liquid-crystal and solid-gel membranes estimated by direct ultraviolet spectrophotometry. Biochim. Biophys. Acta 1988, 946:337-344.
36. Heerklotz H., Seelig J. Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. Biophys. J. 2000, 78:2435-2440.
37. Kim J., et al. Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys. J. 1991, 60:135-148.
38. Bianconi M.L., Schreier S. EPR study of membrane partitioning, orientation, and membrane-modulated alkaline-hydrolysis of a spin-labeled benzoic-acid ester. J. Phys. Chem. 1991, 95:2483-2486.
39. Hartmann T., Schmitt J. Lipophilicity - beyond octanol/water: a short comparison of modern technologies. Drug Discov. Today: Technol. 2004, 1:431-439.
40. Loidl-Stahlhofen A., et al. Multilamellar liposomes and solid-supported lipid membranes (TRANSIL): screening of lipid-water partitioning toward a high-throughput scale. Pharm. Res. 2001, 18:1782-1788.
41. Carrozzino J.M., Khaledi M.G. Interaction of basic drugs with lipid bilayers using liposome electrokinetic chromatography. Pharm. Ress. 2004, 21:2327-2335.
42. Belostotsky, I. et al. (in press) Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients? Biotech. Histochem., doi:10.3109/10520295.2010.483656.
43. Durcekova T., et al. Chemometrical study of the anaesthetical activity of alkoxyphenylcarbamic acid esters. Pharmazie 2010, 65:169-174.
44. Fernandes J.P., et al. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs. Arch. Pharm. (Weinheim) 2010, 343:91-97.
45. Toropov A.A., et al. QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations. Eur. J. Med. Chem. 2010, 45:1639-1647.
46. Short, J. et al. (in press) Practical methods for the measurement of logP for surfactants. Ecotoxicol. Environ.Saf., doi:10.1016/j.ecoenv.2010.03.006.
47. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55:27-55.
48. Black D., Henry B. Found in translation. Realizing the potential of new therapeutic targets. The Biochemist. 2008, 12:28-30.
49. Parexel. (2006) Pharmaceutical R&D Statistical Sourcebook 2005/2006.
50. (2005) Drug Discovery Markets in Europe, Frost & Sullivan.
51. European Commission. (2006) The Community Action Plan on the protection and welfare of animals 2006-2010. (DG Health and Consumer Protection edn), European Commission.
52. Richmond J. 3Rs - past, present and future. Scand. J. Lab. Anim. Sci. 2000, 27:84-92.
53. Balls M. Replacement of Animal Procedures - Alternatives in Research. Education and Testing. Lab. Anim. 1994, 28:193-211.
54. Yesylevskyy S., et al. Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers. Biophys. J. 2009, 97:40-49.
55. Szoka F., Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 1980, 9:467-508.
56. Mayer L.D., et al. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 1986, 858:161-168.
57. Rodriguez N., et al. Giant vesicles formed by gentle hydration and electroformation: a comparison by fluorescence microscopy. Colloids Surf. B Biointerfaces 2005, 42:125-130.
58. Tanford C. The hydrophobic effect: formation of micelles and biological membranes 1991, Krieger.